Zobrazeno 1 - 10
of 106
pro vyhledávání: '"Maria A. V. Willrich"'
Autor:
Patrick W. Mellors, Surendra Dasari, Mindy C. Kohlhagen, Taxiarchis Kourelis, Ronald S. Go, Eli Muchtar, Morie A. Gertz, Shaji K. Kumar, Francis. K. Buadi, Maria A. V. Willrich, John A. Lust, Prashant Kapoor, Martha Q. Lacy, David Dingli, Yi Hwa, Amie Fonder, Miriam Hobbs, Susan Hayman, Rahma Warsame, Nelson R. Leung, Yi Lin, Wilson Gonsalves, Mustaqeem Siddiqui, Robert A. Kyle, S. Vincent Rajkumar, David L. Murray, Angela Dispenzieri
Publikováno v:
Blood Cancer Journal, Vol 11, Iss 3, Pp 1-9 (2021)
Abstract Immunoenrichment-based matrix assisted laser desorption ionization time-of-flight mass spectrometry (MALDI-TOF-MS), termed MASS-FIX, offers several advantages over immunofixation for the detection and isotyping of serum monoclonal protein, i
Externí odkaz:
https://doaj.org/article/bd967d6555a44353ab1424735729b9af
Autor:
Patrick W. Mellors, Surendra Dasari, Mindy C. Kohlhagen, Taxiarchis Kourelis, Ronald S. Go, Eli Muchtar, Morie A. Gertz, Shaji K. Kumar, Francis. K. Buadi, Maria A. V. Willrich, John A. Lust, Prashant Kapoor, Martha Q. Lacy, David Dingli, Yi Hwa, Amie Fonder, Miriam Hobbs, Susan Hayman, Rahma Warsame, Nelson R. Leung, Yi Lin, Wilson Gonsalves, Mustaqeem Siddiqui, Robert A. Kyle, S. Vincent Rajkumar, David L. Murray, Angela Dispenzieri
Publikováno v:
Blood Cancer Journal, Vol 11, Iss 6, Pp 1-2 (2021)
Externí odkaz:
https://doaj.org/article/b71841d0495e4e9aaf162a59bcaf5c7c
Autor:
Maria Alice V. Willrich, David L. Murray, S. Vincent Rajkumar, Sandra C. Bryant, Dirk Larson, Vanessa Pazdernik, Melissa R. Snyder, Robert A. Kyle, Angela Dispenzieri
Publikováno v:
Blood Cancer Journal, Vol 12, Iss 9, Pp 1-4 (2022)
Externí odkaz:
https://doaj.org/article/759dd1a15aa642e69736c1d3ecdd75be
Autor:
Aldo A. Acosta-Medina, Ann M. Moyer, Ronald S. Go, Maria Alice V. Willrich, Fernando C. Fervenza, Nelson Leung, Christianne Bourlon, Jeffrey L. Winters, Grant M. Spears, Sandra C. Bryant, Meera Sridharan
Publikováno v:
Blood Advances. 7:340-350
Eculizumab is effective for complement-mediated thrombotic microangiopathy (CM-TMA), also known as atypical hemolytic uremic syndrome. Although lifelong therapy had been suggested, discontinuation does not universally lead to relapse. Comprehensive d
Autor:
Mark A, Marzinke, William, Clarke, Dennis J, Dietzen, Andrew N, Hoofnagle, Gwendolyn A, McMillin, Maria Alice V, Willrich
Publikováno v:
Journal of Mass Spectrometry and Advances in the Clinical Lab. 27:1-6
Autor:
Susan L. Fink, Mark H. Wener, Joseph W. Rudolf, Ann Nwosu, Danyel H. Tacker, Kamran Kadkhoda, Anne E. Tebo, Maria Alice V. Willrich
Publikováno v:
Clinical Chemistry and Laboratory Medicine (CCLM).
Autor:
Nienke Z. Borren, Emma Paulides, C. Janneke van der Woude, Jody L. Frinack, Maria Alice V. Willrich, Ryan N. Olson, Ashwin N. Ananthakrishnan
Publikováno v:
Digestive Diseases and Sciences, 66(10), 3548-3554. Springer New York
Background: Therapeutic drug monitoring (TDM) is important in optimizing use of biologics in inflammatory bowel diseases (IBD). However, the role of proactive TDM during remission remains uncertain. Methods: This retrospective study included patients
Autor:
Linda J. Tostrud, Vesna D. Garovic, Layan Alrahmani, Ann M. Moyer, Kavita Narang, Maria Alice V. Willrich, Myra J. Wick, Maria L. Gonzalez Suarez, Wendy M. White, Margot A. Cousin
Publikováno v:
Kidney360
BACKGROUND: Preeclampsia and hemolysis, elevated liver enzymes, and low platelets (HELLP) syndrome share many clinical and biologic features with thrombotic microangiopathy syndromes caused by complement abnormalities. Our hypothesis was that similar
Publikováno v:
Clinical Chemistry. 67:1056-1059
Publikováno v:
Journal of Mass Spectrometry and Advances in the Clinical Lab, Vol 21, Iss, Pp 10-18 (2021)
Journal of Mass Spectrometry and Advances in the Clinical Lab
Journal of Mass Spectrometry and Advances in the Clinical Lab
Highlights • Ravulizumab and eculizumab differ by 4 amino acids in their heavy chains. • Validation of ravulizumab LDT with quantitation by intact light chain. • TOF-MS allows for detection by heavy chain.
Introduction Ravulizumab (RAVUL)
Introduction Ravulizumab (RAVUL)